The global ingestible sensor market size reached USD 1,022.8 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 2,692.9 Million by 2033, exhibiting a growth rate (CAGR) of 11.36% during 2025-2033. The increasing prevalence of chronic diseases, rising expenditure capacities of consumers, and extensive research and development (R&D) activities are some of the key factors driving the market.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024 |
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 1,022.8 Million |
Market Forecast in 2033 | USD 2,692.9 Million |
Market Growth Rate (2025-2033) | 11.36% |
An ingestible sensor is a pharmaceutical dosage electronic device that can be swallowed and then travels through the digestive system to collect and transmit patient health data. They are generally about the size of a medicine capsule composed of biocompatible materials and are designed to be swallowed like any other medication. An ingestible sensor is widely used to wirelessly transmit information about various health parameters such as medication adherence, vital signs, pH values, pressure, or core body temperature data and digestive function on a smartphone connected via the Internet. It is a non-invasive alternative that also assists in providing accurate and real-time data on a patient's condition, improving patient monitoring, and enhancing the effectiveness of treatments and medication.
The increasing prevalence of chronic diseases, such as diabetes, heart disease, and gastrointestinal disorders, is one of the key factors driving the market growth. Ingestible sensors are widely used as they offer a non-invasive way to monitor health conditions and improve patient outcomes. In line with this, the widespread adoption of these sensors in capsule endoscopy, patient monitoring, and controlled drug delivery applications is acting as another growth-inducing factor. Moreover, the growing cases of complications caused due to multiple chronic diseases are favoring the market growth. Apart from this, the miniaturization of ingestible sensors that are small and more comfortable to swallow is providing a thrust to the market growth. Additionally, the introduction of ingestible sensors with multiple sensors, allowing them to monitor multiple physiological parameters simultaneously, is positively influencing the market growth. Furthermore, the widespread product utilization as it helps to reduce hospital visits and re-hospitalization and offers round-the-clock remote monitoring, thereby allowing patients to recover within the comforts of their own homes, which in turn is facilitating the market growth. Other factors, including rising expenditure capacities of consumers, widespread adoption among the geriatric population that requires ongoing monitoring, significant growth in the healthcare industry, extensive research and development (R&D) activities, technological advancements, and increasing adoption of the Internet of Things (IoT) in the medical sector and the implementation of various government initiatives to improve healthcare education are anticipated to drive the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global ingestible sensor market report, along with forecasts at the global, regional, and country levels for 2025-2033. Our report has categorized the market based on component, and industry vertical.
Component Insights:
The report has provided a detailed breakup and analysis of the ingestible sensor market based on the component. This includes sensor (temperature sensor, image sensor, Ph sensor, and pressure sensor), wearable patch/data recorder, and software. According to the report, sensor represented the largest segment.
Industry Vertical Insights:
The report has provided a detailed breakup and analysis of the ingestible sensor market based on the industry vertical. This includes healthcare/medical and sport and fitness. According to the report, healthcare/medical represented the largest segment.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for ingestible sensor. Some of the factors driving the North America ingestible sensor market included rising expenditure capacities of consumers, significant growth in the healthcare industry, and rapid technological advancements.
The report has also provided a comprehensive analysis of the competitive landscape in the global ingestible sensor market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Atmo Biosciences, CapsoVision Inc., Check-Cap Ltd., HQ Inc. ,IntroMedic Co. Ltd., JINSHAN Science & Technology (Group) Co. Ltd., Medtronic plc, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Scope of the Report | Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
|
Components Covered |
|
Industry Verticals Covered | Healthcare/Medical, Sport and Fitness |
Regions Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Atmo Biosciences, CapsoVision Inc., Check-Cap Ltd., HQ Inc. ,IntroMedic Co. Ltd., JINSHAN Science & Technology (Group) Co. Ltd., Medtronic plc, etc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |